Skip to main content

Table 2 The major outcomes of the included patients

From: Characteristics and outcomes of Stanford type A aortic dissection patients with severe post-operation hyperbilirubinemia: a retrospective cohort study

Variables Value
In-hospital mortality, n (%) 82 (30.3%)
Cause of death
 Multiple organ failure, n (%) 40 (48.8%)
 Heart failure, n (%) 35 (42.7%)
 Hemorrhagic shock, n (%) 2 (2.4%)
 Sepsis, n (%) 5 (6.1%)
 Reoperation, n (%) 17 (6.3%)
 AKI, n (%) 222 (81.9%)
 Stage of AKI
  Stage 1, n (%) 102 (40.2%)
  Stage 2, n (%) 34 (12.5%)
  Stage 3, n (%) 84 (29.2%)
 Use of CRRT, n (%) 50 (18.5%)
 Use of PE/BA, n (%) 11 (14.1%)
 Use of IABP, n (%) 1 (0.4%)
 Use of ECMO, n (%) 7 (2.6%)
 Use of vasoactive agent, n (%) 173 (63.8%)
 Mechanical ventilation time, mean ± SD (days) 3.3 ± 5.7
 The amount of blood transfusion, mean ± SD (U) 34.8 ± 43.3
 In hospital time, mean ± SD (days) 19.8 ± 10.7
 ICU stay time, mean ± SD (days) 6.6 ± 6.3
 Onset of severe hyperbilirubinemia, mean ± SD (days) 2.8 ± 1.3
  1. AKI Acute kidney injury, BA Bilirubin adsorption, CRRT Continuous renal replacement therapy, ECMO Extracorporeal membrane oxygenation, IABP Intra-aortic balloon pump, ICU Intensive care unit, PE Plasma exchange